Faithward Advisors’s Zimmer Biomet ZBH Stock Holding History

Faithward Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,572	Closed	-$207K	–	273
2024 Q1	$207K	Buy	+1,572	New	+$196K	0.04%	243

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Faithward Advisors's ZBH Position: Q2 2024 in Review

Faithward Advisors sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 1,572 shares — an estimated $207K sold.

Faithward Advisors first reported a position in ZBH in Q1 2024 and held it in 1 quarter. The position peaked at $207K in Q1 2024. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

Faithward Advisors reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
Faithward Advisors sold 1,572 Zimmer Biomet shares in Q2 2024, an estimated $207K.
Faithward Advisors first reported a position in Zimmer Biomet in Q1 2024 and held it in 1 quarter.
Faithward Advisors's Zimmer Biomet position peaked at $207K in Q1 2024.
1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Faithward Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.